Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC] - N0000184318

Pharmacologic Code	N0000184318
Pharmacologic Name	Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy
Pharmacologic Uses	allogeneic cord blood hematopoietic progenitor cell therapy
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	76489-001	Hemacord	Non-Proprietary Name: Human Cord Blood Hematopoietic Progenitor Cell	Injection	Intravenous	New York Blood Center	ACTIVE